SEC Company Response from IMMUNIC, INC. (IMUX) (CIK 0001280776) (IMUX) — Apr 26, 2024
IMMUNIC, INC. (IMUX) (CIK 0001280776)
Date: April 26, 2024 · CIK: 0001280776 · Accession: 0001193805-24-000570
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-277040
Letter
RE: Immunic, Inc.
April 26, 2024
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Hamill
Registration Statement on Form S-3
File No. 333-277040
Filed February 13, 2024
In accordance with Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Immunic, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Tuesday, April 30, 2024 at 5:00 p.m., Eastern Time, or as soon as thereafter practicable.
Please call Ilan Katz of Dentons US LLP at (212) 632-5556 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours,
Immunic, Inc.
Show Raw Text
CORRESP
1
filename1.htm
April 26, 2024
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Hamill
RE: Immunic, Inc.
Registration Statement on Form S-3
File No. 333-277040
Filed February 13, 2024
In accordance with Rule 461
of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Immunic, Inc. (the “Registrant”) hereby
respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement
to Tuesday, April 30, 2024 at 5:00 p.m., Eastern Time, or as soon as thereafter practicable.
Please call Ilan Katz of
Dentons US LLP at (212) 632-5556 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours,
Immunic, Inc.
/s/ Daniel Vitt
Daniel Vitt
President and Chief Executive Officer